These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 15538956)
1. Postmortem redistribution of the enantiomers of citalopram and its metabolites: an experimental study in rats. Kugelberg FC; Druid H; Carlsson B; Ahlner J; Bengtsson F J Anal Toxicol; 2004; 28(8):631-7. PubMed ID: 15538956 [TBL] [Abstract][Full Text] [Related]
2. Early-phase postmortem redistribution of the enantiomers of citalopram and its demethylated metabolites in rats. Kugelberg FC; Kingbäck M; Carlsson B; Druid H J Anal Toxicol; 2005; 29(4):223-8. PubMed ID: 15975250 [TBL] [Abstract][Full Text] [Related]
3. Stereoselective single-dose kinetics of citalopram and its metabolites in rats. Kugelberg FC; Carlsson B; Ahlner J; Bengtsson F Chirality; 2003 Aug; 15(7):622-9. PubMed ID: 12840828 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats. Wikell C; Apelqvist G; Carlsson B; Hjorth S; Bergqvist PB; Kugelberg FC; Ahlner J; Bengtsson F Clin Neuropharmacol; 1999; 22(6):327-36. PubMed ID: 10626092 [TBL] [Abstract][Full Text] [Related]
5. Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver. Rochat B; Kosel M; Boss G; Testa B; Gillet M; Baumann P Biochem Pharmacol; 1998 Jul; 56(1):15-23. PubMed ID: 9698084 [TBL] [Abstract][Full Text] [Related]
6. In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats. Kugelberg FC; Apelqvist G; Carlsson B; Ahlner J; Bengtsson F Br J Pharmacol; 2001 Apr; 132(8):1683-90. PubMed ID: 11309239 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450-dependent disposition of the enantiomers of citalopram and its metabolites: in vivo studies in Sprague-Dawley and Dark Agouti rats. Kingbäck M; Carlsson B; Ahlner J; Bengtsson F; Kugelberg FC Chirality; 2011 Feb; 23(2):172-7. PubMed ID: 20848647 [TBL] [Abstract][Full Text] [Related]
8. Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy. Apelqvist G; Wikell C; Carlsson B; Hjorth S; Bergqvist PB; Ahlner J; Bengtsson F Clin Neuropharmacol; 2000; 23(6):304-17. PubMed ID: 11575864 [TBL] [Abstract][Full Text] [Related]
9. Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: an innovatory robustness/ruggedness study. Berzas-Nevado JJ; Villaseñor-Llerena MJ; Guiberteau-Cabanillas C; Rodríguez-Robledo V Electrophoresis; 2006 Feb; 27(4):905-17. PubMed ID: 16470634 [TBL] [Abstract][Full Text] [Related]
10. Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC. Rochat B; Amey M; Van Gelderen H; Testa B; Baumann P Chirality; 1995; 7(6):389-95. PubMed ID: 7577348 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997. Reis M; Lundmark J; Bengtsson F Ther Drug Monit; 2003 Apr; 25(2):183-91. PubMed ID: 12657912 [TBL] [Abstract][Full Text] [Related]
12. Influence of blood loss on the pharmacokinetics of citalopram. Kugelberg FC; Alkass K; Kingbäck M; Carlsson B; Druid H Forensic Sci Int; 2006 Sep; 161(2-3):163-8. PubMed ID: 16839729 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic consequences of a citalopram treatment discontinuation. Voirol P; Rubin C; Bryois C; Kosel M; Buclin T; Baumann P Ther Drug Monit; 1999 Jun; 21(3):263-6. PubMed ID: 10365634 [TBL] [Abstract][Full Text] [Related]
14. Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites. Unceta N; Goicolea MA; Barrio RJ Biomed Chromatogr; 2011 Jan; 25(1-2):238-57. PubMed ID: 21058412 [TBL] [Abstract][Full Text] [Related]
15. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors. Ceglia I; Acconcia S; Fracasso C; Colovic M; Caccia S; Invernizzi RW Br J Pharmacol; 2004 Jun; 142(3):469-78. PubMed ID: 15148253 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting. Reis M; Olsson G; Carlsson B; Lundmark J; Dahl ML; Wålinder J; Ahlner J; Bengtsson F J Clin Psychopharmacol; 2002 Aug; 22(4):406-13. PubMed ID: 12172341 [TBL] [Abstract][Full Text] [Related]
17. Plasma levels of citalopram enantiomers and metabolites in elderly patients. Foglia JP; Pollock BG; Kirshner MA; Rosen J; Sweet R; Mulsant B Psychopharmacol Bull; 1997; 33(1):109-12. PubMed ID: 9133760 [TBL] [Abstract][Full Text] [Related]
18. Enantioselective analysis of citalopram and its metabolites in postmortem blood and genotyping for CYD2D6 and CYP2C19. Holmgren P; Carlsson B; Zackrisson AL; Lindblom B; Dahl ML; Scordo MG; Druid H; Ahlner J J Anal Toxicol; 2004 Mar; 28(2):94-104. PubMed ID: 15068562 [TBL] [Abstract][Full Text] [Related]
19. Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats. Rocha A; Coelho EB; Lanchote VL Can J Physiol Pharmacol; 2008 Nov; 86(11):770-6. PubMed ID: 19011672 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography. Kosel M; Eap CB; Amey M; Baumann P J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):234-8. PubMed ID: 9869386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]